Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | THPO | P40225 | 1/20 | 0.38 |
| ▸ | PPM1B | O75688 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.38 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.38 |
| ▸ | PPP5C | P53041 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7098039 | 0.72 | PTPN1 (0.39) | LMNAMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL17893334 | 0.68 | LMNA (0.39) | LMNAMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL13809215 | 0.68 | LMNA (0.39) | LMNAMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL426068 | 0.68 | LMNA (0.39) | LMNAMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL7103950 | 0.68 | LMNA (0.39) | LMNAMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL7099395 | 0.68 | LMNA (0.39) | LMNAMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL13946305 | 0.68 | LMNA (0.39) | LMNAMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL2385770 | 0.67 | LMNA (0.52) | LMNAMEN1MAPTKMT2AALDH1A1 | |
| Methylamine SCHEMBL27490883 | 0.65 | LMNA (0.37) | LMNAMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL2245538 | 0.62 | NR1I2 (0.47) | LMNAMEN1MAPTKMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150266810-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION | V-BAC HOLDING CORP. (CA) | 2015-09-24 | — | — | US | claimed |
| US-20130190296-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION | DENDREON CORPORATION (US) | 2013-07-25 | — | — | US | claimed |
| US-7271192-B2 | Substituted 2-pyrrolidine-2-yl-1H-indole compounds | GRUENENTHAL GMBH (DE) | 2007-09-18 | — | — | US | claimed |
| EP-1663962-A4 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION | DENDREON CORP (US) | 2007-08-22 | — | — | EP | claimed |
| EP-1451177-B1 | SUBSTITUTED 2-PYRROLIDINE-2-YL-1H-INDOLE DERIVATIVES FOR THE TREATMENT OF MIGRAINE | GRUENENTHAL GMBH (DE) | 2007-03-21 | — | — | EP | claimed |
| JP-2007503392-A | — | — | 2007-02-22 | — | — | JP | claimed |
| EP-1663962-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION | DENDREON CORPORATION (US) | 2006-06-07 | — | — | EP | claimed |
| JP-2005511694-A | — | — | 2005-04-28 | — | — | JP | claimed |
| US-20050054651-A1 | Compositions and methods for the treatment of disease associated with Trp-p8 expression | DENDREON CORPORATION (US) | 2005-03-10 | — | — | US | claimed |
| WO-2005020897-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION | DENDREON CORPORATION (US) | 2005-03-10 | — | — | WO | claimed |
| US-20050043369-A1 | Bactericidal antimicrobial methods and compositions for use in treating gram positive infections | PROTEZ PHARMACEUTICALS INC. (US) | 2005-02-24 | — | — | US | claimed |
| US-20050014815-A1 | Substituted 2-pyrrolidine-2-yl-1H-indole compounds | GRUENENTHAL GMBH (DE) | 2005-01-20 | — | — | US | claimed |
| EP-1451177-A1 | SUBSTITUTED 2-PYRROLIDINE-2-YL-1H-INDOLE DERIVATIVES FOR THE TREATMENT OF MIGRAINE | Grünenthal GmbH (DE) | 2004-09-01 | — | — | EP | claimed |
| US-20030225126-A1 | Bactericidal antimicrobial methods and compositions for use in treating gram positive infections | INFLUX, INC. | 2003-12-04 | — | — | US | claimed |
| WO-2003048156-A1 | SUBSTITUTED 2-PYRROLIDINE-2-YL-1H-INDOLE DERIVATIVES FOR THE TREATMENT OF MIGRAINE | Grünenthal GmbH (DE) | 2003-06-12 | — | — | WO | claimed |
| EP-1296688-A2 | BACTERICIDAL ANTIMICROBIAL METHODS AND COMPOSITIONS FOR USE IN TREATING GRAM POSITIVE INFECTIONS COMPRISING AN ANTIBIOTIC POTENTIATOR HAVING ACYL HYDRAZIDE, OXY AMIDE OR 8-HYDROXY QUINOLINE STRUCTURE | Influx, Inc. (US) | 2003-04-02 | — | — | EP | claimed |
| WO-2001070213-A2 | BACTERICIDAL ANTIMICROBIAL METHODS AND COMPOSITIONS FOR USE IN TREATING GRAM POSITIVE INFECTIONS COMPRISING AN ANTIBIOTIC POTENTIATOR HAVING ACYL HYDRAZIDE OXY AMIDE OR 8-HYDROXY QUINOLINE STRUCTURE | INFLUX, INC. (US) | 2001-09-27 | — | — | WO | claimed |
| US-11693313-B2 | Resist composition and method of forming resist pattern | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-07-04 | — | — | US | disclosed |
| EP-1296688-A2 | BACTERICIDAL ANTIMICROBIAL METHODS AND COMPOSITIONS FOR USE IN TREATING GRAM POSITIVE INFECTIONS COMPRISING AN ANTIBIOTIC POTENTIATOR HAVING ACYL HYDRAZIDE, OXY AMIDE OR 8-HYDROXY QUINOLINE STRUCTURE | Influx, Inc. (US) | 2003-04-02 | — | — | EP | disclosed |
| WO-2001070213-A2 | BACTERICIDAL ANTIMICROBIAL METHODS AND COMPOSITIONS FOR USE IN TREATING GRAM POSITIVE INFECTIONS COMPRISING AN ANTIBIOTIC POTENTIATOR HAVING ACYL HYDRAZIDE OXY AMIDE OR 8-HYDROXY QUINOLINE STRUCTURE | INFLUX, INC. (US) | 2001-09-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11693313-B2 | Resist composition and method of forming resist pattern | C1R, C1S, C9 | LMNA 611/4885MEN1 1250/4885MAPT 3206/4885 |
| US-20030225126-A1 | Bactericidal antimicrobial methods and compositions for use in treating gram positive infections | NAAA, TLR8, OPA1 | LMNA 3860/4885MEN1 4613/4885MAPT 4741/4885 |
| US-20050014815-A1 | Substituted 2-pyrrolidine-2-yl-1H-indole compounds | IDO1, IDO2, TPH2 | LMNA 2400/4885MEN1 2162/4885MAPT 697/4885 |
| US-20130190296-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION | TRPC4, TRPC3, TRPC1 | LMNA 2189/4885MEN1 2360/4885MAPT 2258/4885 |
| US-20150266810-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION | TRPC4, TRPC3, TRPC1 | LMNA 2320/4885MEN1 2225/4885MAPT 2269/4885 |
| US-20050043369-A1 | Bactericidal antimicrobial methods and compositions for use in treating gram positive infections | NAAA, TLR8, OPA1 | LMNA 3860/4885MEN1 4613/4885MAPT 4741/4885 |
| US-20050054651-A1 | Compositions and methods for the treatment of disease associated with Trp-p8 expression | TRPC4, TRPC3, TRPC1 | LMNA 1738/4885MEN1 2516/4885MAPT 3379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.